Safety and cost-effectiveness of outpatient autologous transplantation for multiple myeloma in Asia: single-center perspective from Singapore

Bone Marrow Transplant. 2017 Jul;52(7):1044-1046. doi: 10.1038/bmt.2017.77. Epub 2017 May 8.

Authors

M B Abid¹, D Christopher², M A Abid³, M L Poon¹, L K Tan¹, L P Koh¹, W J Chng¹

Affiliations

¹ Department of Hematology/Oncology, National University Cancer Institute Singapore (NCIS), Singapore, Singapore.
² Department of Hematology, Tan Tock Seng Hospital Singapore, Singapore, Singapore.
³ Department of Otolaryngology - Head &Neck Surgery, Johns Hopkins University, Baltimore, MD, USA.

PMID: 28481354
DOI: 10.1038/bmt.2017.77

No abstract available

Publication types

Randomized Controlled Trial

MeSH terms

Adult
Ambulatory Care* / economics
Ambulatory Care* / methods
Autografts
Case-Control Studies
Costs and Cost Analysis
Female
Hematopoietic Stem Cell Transplantation / economics*
Humans
Male
Middle Aged
Multiple Myeloma* / economics
Multiple Myeloma* / therapy
Safety*
Singapore